Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
bins decrease » point decrease (Expand Search), sizes decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
bins decrease » point decrease (Expand Search), sizes decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
-
1961
-
1962
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
1963
-
1964
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
1965
-
1966
-
1967
-
1968
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
1969
-
1970
-
1971
-
1972
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
1973
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
1974
-
1975
-
1976
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
1977
-
1978
-
1979
-
1980